In 2017, Green Bay Packers quarterback Aaron Rodgers broke his right collarbone in a game against the Minnesota Vikings. Typically, it takes about 12 weeks for a collarbone to fully heal, but by mid-December fans and commentators ...
Jul 6, 2021
1
162
Advances in the fields of biomaterials and nanotechnology could lead to big breakthroughs in the fight against dangerous viruses like the novel coronavirus that causes COVID-19.
Feb 9, 2021
0
33
Researchers developed a new class of medical instruments equipped with an advanced soft electronics system that could dramatically improve the diagnoses and treatments of a number of cardiac diseases and conditions.
Sep 7, 2020
0
247
Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues. But the promising approach can only work if the drug hits its target.
Aug 9, 2019
0
50
Doctors could soon get some help from an artificial intelligence tool when diagnosing brain aneurysms—bulges in blood vessels in the brain that can leak or burst open, potentially leading to stroke, brain damage or death.
Jun 7, 2019
0
184
A new Yale study finds that M.D.-Ph.D. programs in the United States have become less socioeconomically diverse in recent years. Between 2014 and 2019, applicants from families with higher household incomes were accepted ...
Mar 12, 2024
0
0
Medical students with co-occurring disabilities are more likely than their peers to experience burnout, a new Yale study finds. That risk increases if the student identifies as Asian or in a racial or ethnic group typically ...
Jan 10, 2024
0
0
Despite an alarming increase in overdose deaths among young people nationwide, a new "secret shopper"-style study led by Oregon Health & Science University researchers finds that access to residential addiction treatment ...
Jan 8, 2024
0
0
At a time when some industries are shying away from and questioning the use of AI in daily work, those in the medical field are leaning into the support the technology can provide to doctors.
Jan 5, 2024
0
1
A phase III LIBRETTO-431 multicenter study has evaluated the efficacy and safety of selpercatinib compared to control treatment, which consisted of platinum-based chemotherapy associated or not with pembrolizumab (immune ...
Jan 5, 2024
0
1
